Related Experiment Video

Updated: Jun 30, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Severe left ventricular systolic dysfunction may reverse with renal transplantation: uremic cardiomyopathy and

R Zolty1, P J Hynes, T J Vittorio

  • 1Albert Einstein College of Medicine, Division of Cardiology, Bronx, NY, USA.

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|September 24, 2008
PubMed

Insights

Kidney transplantation can improve cardiac function in patients with chronic heart failure and chronic kidney disease. It corrects the uremic state, potentially reversing left ventricular hypertrophy and dilatation.

Area of Science:

  • Nephrology
  • Cardiology
  • Transplantation Medicine

Background:

  • Chronic heart failure (CHF) and chronic kidney disease (CKD) are linked by complex interactions affecting morbidity and mortality.
  • CKD commonly causes cardiac abnormalities like left ventricular hypertrophy (LVH) and diastolic/systolic dysfunction.
  • LV systolic dysfunction was historically considered a contraindication for renal transplantation.

Purpose of the Study:

  • To evaluate the impact of renal transplantation on cardiac function in patients with CKD.
  • To determine if renal transplantation can improve or reverse cardiac abnormalities associated with uremic cardiomyopathy.

Main Methods:

  • Observational studies analyzing cardiac function before and after renal transplantation.
  • Assessment of left ventricular hypertrophy (LVH), dilatation (LVD), and systolic/diastolic function post-transplant.
  • Correlation of cardiac improvements with renal function and hypertension control.

Main Results:

  • Renal transplantation can lead to significant improvement in left ventricular systolic function.
  • Correction of the uremic state post-transplant improves LVD and may cause regression of LVH.
  • LVH reduction is associated with adequate renal function and hypertension management; diabetes is not a confounding factor.

Conclusions:

  • Renal transplantation is a viable option for patients with CKD and cardiac dysfunction.
  • Transplantation offers a potential therapeutic strategy to improve cardiovascular outcomes in this population.
  • Management of renal function and blood pressure is crucial for optimizing cardiac benefits post-transplant.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...